Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced Leukemic cells

Leukemia

Volumn 11, Issue SUPPL. 3, 1997, Pages 577-581

  Hirano, Naoto ^a   Takahashi, Tsuyoshi ^a   Takahashi, Tokiharu ^a   Azuma, Miyuki ^b   Yazaki, Yoshio ^a   Yagita, Hideo ^b   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; LEUKEMIA; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

EID: 0030753175     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Wallich R. et al. Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 1985; 315: 301-305.
2. Ostrand-Rosenberg S. et al. Rejection of mouse sarcoma cells after transfection of MHC class II genes. J. Immunol. 1990; 144 : 4068-4071.
3. Chen L et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71 : 1093-1102.
4. Dranoff G. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U S A. 1993; 90 : 3539-3543.